The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

OIG re­port ac­cus­es FDA of not fol­low­ing poli­cies for for­eign drug in­spec­tions

3 years ago
Pharma
FDA+

WuXi Bi­o­log­ics in­spec­tion rais­es prospects for get­ting off US 'un­ver­i­fied list' — re­port

3 years ago
Outsourcing

Lon­za to in­vest $500M+ on fill-fin­ish fa­cil­i­ty on its home turf

3 years ago
Financing

US gov­ern­ment more than dou­bles the sup­ply of mon­key­pox vac­cine

3 years ago
Pharma

ICM­RA to launch sev­er­al reg­u­la­to­ry pi­lot pro­grams cen­tered around man­u­fac­tur­ing in­spec­tions

3 years ago
FDA+

Man­u­fac­tur­ing roundup: Teru­mo BCT part­ners with Bio­Bridge sub­sidiary to man­u­fac­ture cell and gene ther­a­pies; WuXi STA opens plant for HPA­PI pro­duc­tion

3 years ago

No­var­tis to re­sume the pro­duc­tion of two ra­di­oli­gand ther­a­pies af­ter re­solv­ing qual­i­ty is­sues

3 years ago
Pharma

FDA slaps warn­ing let­ter on Min­neso­ta API fa­cil­i­ty af­ter em­ploy­ee de­stroys clean­ing log

3 years ago
FDA+

Fu­ji­film in­vests an­oth­er $1.6B in­to its CD­MO arm to up­grade facil­lites in the US and Eu­rope

3 years ago
Financing

Am­gen sells its Turk­ish man­u­fac­tur­ing arm for $135M

3 years ago
Deals

Vedan­ta opens man­u­fac­tur­ing fa­cil­i­ty to pro­duce lead can­di­date as it heads for PhI­II

3 years ago
Pharma

Au­robindo Phar­ma re­ceives warn­ing let­ter from In­di­a's SEC fol­low­ing more FDA ques­tion marks

3 years ago
Pharma
FDA+

Charles Riv­er Lab­o­ra­to­ries to start cell and gene ther­a­py man­u­fac­tur­ing at UK site in Sep­tem­ber

3 years ago

Alex­ion puts €65M for­ward to strength­en its po­si­tion on the Emer­ald Isle

3 years ago
Financing
Pharma

Biden and G7 na­tions of­fer funds for vac­cine and med­ical prod­uct man­u­fac­tur­ing project in Sene­gal

3 years ago
Financing

EU to launch vac­cine de­vel­op­ment and man­u­fac­tur­ing part­ner­ship with Latin Amer­i­can and Caribbean coun­tries

3 years ago
Financing

Man­u­fac­tur­ing roundup: GSK opens a new fa­cil­i­ty at Barnard Cas­tle lo­ca­tion; Tenaya Ther­a­peu­tics com­pletes build­out of Bay Area ge­net­ic med­i­cine man­u­fac­tur­ing site

3 years ago

FDA warns Mex­i­can glyc­erin man­u­fac­tur­er for re­fus­ing an in­spec­tion

3 years ago
FDA+

Mil­li­pore­Sig­ma looks to keep up with the com­pe­ti­tion in new Wis­con­sin ex­pan­sion

3 years ago

BioN­Tech breaks ground on first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Africa

3 years ago
Coronavirus

As­traZeneca con­tin­ues to build out its pres­ence in Chi­na with new COPD drug man­u­fac­tur­ing site

3 years ago
China

Mod­er­na to se­cure a UK pres­ence with $1B+ in new man­u­fac­tur­ing and R&D fa­cil­i­ties

3 years ago
Pharma
Coronavirus

PIC/S to re­sume on­site as­sess­ments for coun­tries ap­ply­ing for mem­ber­ship

3 years ago
Pharma

Cen­ter for Break­through Med­i­cines plans for an even larg­er dive in­to cell ther­a­py man­u­fac­tur­ing

3 years ago
First page Previous page 49505152535455 Next page Last page
A service from the Financial Times